Measure | Statistic |
Age (years, median, IQR) | 78 (67–84) |
Male (n, %) | 449 (68) |
Female (n, %) | 207 (32) |
Initial GCS (median, IQR) | 14 (14–15) |
Mild impairment (13–15, n, %) | 540 (82) |
Moderate impairment (9–12, n, %) | 103 (16) |
Severe impairment (3–8, n, %) | 13 (2) |
Comorbidities (n, %) | |
Diabetes mellitus | 109 (17) |
Dementia | 73 (11) |
COPD | 36 (5) |
IHD | 169 (26) |
CVA | 103 (16) |
Malignancy | 55 (8) |
Anticoagulation (n, %) | |
Warfarin use | 124 (19) |
Antiplatelet medication use | 157 (24) |
Initial mRS (median, IQR) | 3 (2–4) |
Length of stay (days, median, IQR) | 7 (5–12) |
Recollection / reoperation within 60 days (n, %) | 59 (9) |
Patients in each time to surgery (days) category (n, %) | |
0 days | 133 (20) |
1 day | 241 (37) |
2 days | 104 (16) |
3–6 days | 100 (15) |
7+ days | 78 (12) |
COPD, Chronic obstuctive pulmonary disease; CVA, Cerebrovascular accident; GCS, Glasgow Coma Scale; IHD, Ischaemic heart disease ; mRS, modified Rankin Scale.